Identification of Potent DNA Gyrase Inhibitors Active against Mycobacterium tuberculosis. - Bongkochawan Pakamwong; Paptawan Thongdee; Bundit Kamsri; Naruedon Phusi; Pharit Kamsri; Auradee Punkvang; Sombat Ketrat; Patchreenart Saparpakorn; Supa Hannongbua; Kanchiyaphat Ariyachaokun; Khomson Suttisintong; Sanya Sureram; et al. (J. Chem. Inf. Model., 2022)

Virtual Screening Identifies Novel and Potent Inhibitors of Mycobacterium tuberculosis PknB with Antibacterial Activity. - Paptawan Thongdee; Chayanin Hanwarinroj; Bongkochawan Pakamwong; Pharit Kamsri; Auradee Punkvang; Jiraporn Leanpolchareanchai; Sombat Ketrat; Patchreenart Saparpakorn; Supa Hannongbua; Kanchiyaphat Ariyachaokun; Khomson Suttisintong; Sanya Sureram; et al. (J. Chem. Inf. Model., 2022)

Structure-based drug design of novel M. tuberculosis InhA inhibitors based on fragment molecular orbital calculations. - Naruedon Phusi; Yuta Hashimoto; Naoki Otsubo; Kyohei Imai; Paptawan Thongdee; Darunee Sukchit; Pharit Kamsri; Auradee Punkvang; Khomson Suttisintong; Pornpan Pungpo; Noriyuki Kurita (Comput. Biol. Medicine, 2023)

Bioisosteric Design Identifies Inhibitors of Mycobacterium tuberculosis DNA Gyrase ATPase Activity. - Bundit Kamsri; Bongkochawan Pakamwong; Paptawan Thongdee; Naruedon Phusi; Pharit Kamsri; Auradee Punkvang; Sombat Ketrat; Patchreenart Saparpakorn; Supa Hannongbua; Jidapa Sangswan; Khomson Suttisintong; Sanya Sureram; et al. (J. Chem. Inf. Model., 2023)

Ligand-Based Virtual Screening for Discovery of Indole Derivatives as Potent DNA Gyrase ATPase Inhibitors Active against Mycobacterium tuberculosis and Hit Validation by Biological Assays. - Bongkochawan Pakamwong; Paptawan Thongdee; Bundit Kamsri; Naruedon Phusi; Somjintana Taveepanich; Kampanart Chayajarus; Pharit Kamsri; Auradee Punkvang; Supa Hannongbua; Jidapa Sangswan; Khomson Suttisintong; Sanya Sureram; et al. (J. Chem. Inf. Model., 2024)